| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/31/2002 | EP1226143A2 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors |
| 07/31/2002 | EP1226137A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/31/2002 | EP1226132A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 07/31/2002 | EP1226126A1 Pyrimidine derivatives |
| 07/31/2002 | EP1226115A1 Novel carbamates and ureas |
| 07/31/2002 | EP1226112A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 07/31/2002 | EP1225955A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 07/31/2002 | EP1225915A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/31/2002 | EP1225904A2 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infection |
| 07/31/2002 | EP1225900A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/31/2002 | EP1225897A2 Composition for treatment of constipation and irritable bowel syndrome |
| 07/31/2002 | EP1225894A1 Fab i inhibitors |
| 07/31/2002 | EP1225801A1 Propagation of human hepatocytes in non-human animals |
| 07/31/2002 | EP0708656B1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 07/31/2002 | EP0698109B1 Gene transfer into pancreatic epithelial cells |
| 07/31/2002 | CN1361793A Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 07/31/2002 | CN1361785A Titanium derived compounds, preparation and use thereof |
| 07/31/2002 | CN1361783A Thiazoloderivatives and pharmaceutical compositions containing them |
| 07/31/2002 | CN1361782A Substituted imidazothiazoles as antidepressant agents |
| 07/31/2002 | CN1361779A New compounds |
| 07/31/2002 | CN1361773A Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/31/2002 | CN1361767A 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 07/31/2002 | CN1361763A Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha |
| 07/31/2002 | CN1361694A Glycyrrhizin preparations for transmucosal absorption |
| 07/31/2002 | CN1361692A Novel use of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 07/31/2002 | CN1361690A Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 07/31/2002 | CN1361687A Phosphate transport inhibitors |
| 07/31/2002 | CN1361677A Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 07/31/2002 | CN1360946A Medicinal composition containing rummyfudin and transfer factor |
| 07/31/2002 | CN1360943A Chinese medicine prepn with functions of resisting senility, resisting fatigue and treating women's asexuality |
| 07/31/2002 | CN1360923A Chinese herb medicine composition with kidney-reinforcing and blood circulation-promoting functions |
| 07/31/2002 | CN1360918A Nanometer zhuhuang medicine and its prepn |
| 07/31/2002 | CN1360910A Nanometer xiaoyao medicine preparation and its preparing method |
| 07/31/2002 | CN1360909A Nanometer cinobufagin medicine and its prepn |
| 07/31/2002 | CN1360901A Snuff xinnaokang for treating cardiovascular and cerebrovascular disease |
| 07/31/2002 | CN1360855A Multielement calcium-rich liver-protecting sobering up beverage |
| 07/31/2002 | CN1088378C Oral Chinese medicine liquid for treating chronic superficial gastritis and its preparation method |
| 07/31/2002 | CN1088370C Tonguan shugan ointment and preparation process thereof |
| 07/31/2002 | CN1088365C Medicine for treating infections gastrosis and its preparing process |
| 07/31/2002 | CN1088363C Medicine for curing children insufficiency of the spleen and anorexia and its preparing method |
| 07/31/2002 | CA2369462A1 Nicotinamide acids, amides, and their mimetics active as inhibitors of pde4 isozymes |
| 07/30/2002 | US6426413 Inhibitors of caspases |
| 07/30/2002 | US6426411 PGC-1, a novel brown fat pparγ coactivator |
| 07/30/2002 | US6426402 Respiratory system disorders; rheumatic diseases |
| 07/30/2002 | US6426369 Oxethazaine as antimicrobial agent |
| 07/30/2002 | US6426368 Method for preventing and treating alcoholism |
| 07/30/2002 | US6426359 Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists |
| 07/30/2002 | US6426348 For therapy of inflammation associated with chronic inflammatory diseases such as rheumatoid arthritis (ra), multiple sclerosis, (ms), asthma, and inflammatory bowel disease (i bd) |
| 07/30/2002 | US6426201 Mixing cereal with water; freezing |
| 07/30/2002 | US6426199 Isolated, purified nucleic acid detecting or isolating mutant forms of the dna molecules. |
| 07/30/2002 | US6426069 Method and compositions for increasing intestinal absorption of fats |
| 07/30/2002 | US6426068 Prevent cell or organ degradation; plant extracts |
| 07/30/2002 | US6426066 Use of physiologically balanced, ionized, acidic solution in wound healing |
| 07/30/2002 | CA2344707C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 07/30/2002 | CA2268433C Improved interferon polymer conjugates |
| 07/30/2002 | CA2236021C Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities: process of making metho ds of using and compositions thereof |
| 07/30/2002 | CA2217157C Inhibition of c. difficile infections by indigestible oligosaccharides |
| 07/30/2002 | CA2104461C Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 07/25/2002 | WO2002057778A1 Screening assay for cotranslational translocation interfering compounds |
| 07/25/2002 | WO2002057460A2 Polynucleotides encoding human phosphatases |
| 07/25/2002 | WO2002057454A2 Receptors and membrane-associated proteins |
| 07/25/2002 | WO2002057453A2 Polypetides and nucleic acids encoding same |
| 07/25/2002 | WO2002057452A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | WO2002057425A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/25/2002 | WO2002057314A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 07/25/2002 | WO2002057309A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/25/2002 | WO2002057306A1 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions |
| 07/25/2002 | WO2002057298A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | WO2002057287A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/25/2002 | WO2002057265A1 Compounds substituted with bicyclic amino groups |
| 07/25/2002 | WO2002057261A2 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002057254A1 Compositions for prevention or treatment of hepatopathy |
| 07/25/2002 | WO2002057253A2 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders |
| 07/25/2002 | WO2002057250A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 07/25/2002 | WO2002057242A2 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | WO2002057237A1 Hetero-tricyclic compounds having substituted amino groups |
| 07/25/2002 | WO2002057230A1 Il-8 receptor antagonists |
| 07/25/2002 | WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | WO2002056915A2 Complex of modafinil and cyclodextrin |
| 07/25/2002 | WO2002056900A2 Use of slpi for treating chronic inflammatory intestinal diseases |
| 07/25/2002 | WO2002056895A2 Ionene polymers and their use in treating mucositis |
| 07/25/2002 | WO2002056893A1 Novel receptors for $i(helicobacter pylori) and use thereof |
| 07/25/2002 | WO2002056890A1 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss |
| 07/25/2002 | WO2002056877A1 Treatment of sleep disturbances |
| 07/25/2002 | WO2002056875A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | WO2002056790A2 Delivery of therapeutic capable agents |
| 07/25/2002 | WO2002039988A3 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 07/25/2002 | WO2002039879A3 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 07/25/2002 | WO2002032901A3 Bridged piperazine derivatives |
| 07/25/2002 | WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2002018379A3 7-oxo pyridopyrimidines |
| 07/25/2002 | WO2002015886A3 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001078781A9 Methods for prevention and treatment of gastrointestinal disorders |
| 07/25/2002 | WO2001077685A3 Diagnosis and treatment of gastrointestinal disease |
| 07/25/2002 | WO2001030812A9 Activation of hcv-specific t cells |
| 07/25/2002 | WO2001002567A9 16405 receptor, a g-protein coupled receptor |
| 07/25/2002 | WO2001000812A9 22012, a novel human carboxypeptidase |